Abstract
Introduction
Recent studies suggest that RCC detected in young adults is likely to be more symptomatic and potentially aggressive, since young patients are less likely to undergo radiologic examinations unless they have symptoms. The aim of this study is to identify the clinical, biological and histological entities of RCC in young patients, and to compare survival rates for symptomatic and asymptomatic patients.
Patients and methods
A review of 2,510 records of patients with RCC from 1965 to 2007 was conducted. Thirty-four patients under 35 years old were identified. The Kaplan–Meier system was used to calculate the cumulative survival rate at five and ten years post-surgery as well as the survival prognoses for patients who presented with symptoms and for patients for whom RCC was incidentally diagnosed.
Results
The differences in cumulative survival rates at five and ten years between patients who presented with symptoms and patients whom RCC was incidentally diagnosed were not significant (P = 0.06). The Kaplan–Meier system used to calculate the cumulative survival rate at five and ten years post-surgery yielded survival rates of 79.4% at five years and 73.5% at ten years, respectively.
Discussion
The biological and histological entities as well as the survival prognosis for RCC in young patients are similar to those for patients who present with RCC in the sixth and seventh decades of life. Additionally, young adults are likely to be more symptomatic, but the difference in survival between patients with symptoms and those without symptoms is not statistically significant.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lieber MM, Tomera FM, Taylor WF, Farrow GM (1981) Renal adenocarcinoma in young adults: survival and variables affecting prognosis. J Urol 125:164–168
Goetzl MA, Desai M, Mansukhani M et al (2004) Natural history and clinical outcome of sporadic renal cortical tumors diagnosed in the young adult. Urology 63:41–45
Eggener SE, Rubenstein JR, Smith ND et al (2004) Renal tumors in young adults. J Urol 171:106–110
Asanuma H, Nakai H, Takeda M et al (1999) Renal cell carcinoma in children: experience at a single institution in Japan. J Urol 162:1402–1405
Labanaris AP, Schott GE, Zugor V (2007) Renal cell carcinoma in children under 10 years old: a presentation of four cases. Pediatr Surg Int. 23(4):327–330
Patrard JJ, Rodriguez A, Rioux-Leclercq N, Guille F, Lobel B (2002) Prognostic significance of the mode of detection in renal tumors. BJU Int 90:358–363
Kato M, Suzuki T, Suzuki Y, Terasawa Y, Sasano H, Arai Y (2004) Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis. J Urol 172:863–866
Tsui KH, Shvarts O, Smith RB, Figlin R, de Kernion JB, Belldergun A (2001) Renal cell carcinoma: prognostic significance of incidental detected tumors. J Urol 165:426–430
Schips L, Lipsky K, Zigeuner R et al (2003) Impact of tumor associated symptoms on the prognosis of patients with renal cell carcinoma: a single center experiences of 683 patients. Urology 62:1024–1028
Yusim I, Mermershtain W, Neulander E et al (2002) Influence of age on the prognosis of patients with renal cell carcinoma (RCC). Onkologie 25:548–550
Abou El Fettouh HI, Cherullo EE, El-Jack M et al (2002) Sporadic renal cell carcinoma in young adults: presentation, treatment, and outcome. Urology 60:806–810
Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics: 1999. CA Cancer J Clin 49:8–31
Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr (1999) Rising incidence of renal cell cancer in the United States. J Am Med Assoc 281:1628–1631
McLaughlin JK, Lindblad P, Mellemgaard A et al (1995b) International renal cell cancer study: I. Tobacco use. Int J Cancer 60:194–198
Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) Pathology and genetics of tumors of the urinary system and male genital organs (World Health Organisation Classification of Tumors). IARC Press, Lyons, p 7
Pantuck AJ, Belldegrun AS, Figlin RA (2001) Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma. N Engl J Med 345:1711
Schafhauser W, Ebert A, Brod J, Petsch S, Schrott KM (1999) Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy. Anticancer Res 19(2C):1573–1578
Lerner SE, Hawkins CA, Blute ML, Grabner A, Wollan PC, Eickholt JT, Zincke H (2002) Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 167(2 Pt 2):884–889
Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR (1995) Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology 45:34–40
Levy DA, Slaton JW, Swanson DA et al (1998) Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 159:1163–1167
Ljungberg B, Hanbury DC, Kuczyk MA, Merseburger AS, Mulders PF, Patard JJ, Sinescu IC (2007) The European Association of Urology Guideline Group for renal cell carcinoma. Renal cell carcinoma guideline. Eur Urol 51(6):1502–1510
Skolarikos A, Alivizatos G, Laguna P, de la Rosette J (2007) A review on follow-up strategies for renal cell carcinoma after nephrectomy. Eur Urol 51(6):1490–1500
Ljungberg B, Alamdari FI, Rasmuson T et al (1999) Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 84:405–411
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zugor, V., Fridel, S., Lausen, B. et al. Renal cell carcinoma under 35 years of age: comparison of survival rates for symptomatic and asymptomatic patients. Int Urol Nephrol 40, 289–293 (2008). https://doi.org/10.1007/s11255-007-9274-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-007-9274-y